These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36111258)

  • 1. CDK12 regulates co-transcriptional splicing and RNA turnover in human cells.
    Magnuson B; Bedi K; Narayanan IV; Bartkowiak B; Blinkiewicz H; Paulsen MT; Greenleaf A; Ljungman M
    iScience; 2022 Sep; 25(9):105030. PubMed ID: 36111258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma.
    Pitolli C; Marini A; Guerra M; Pieraccioli M; Marabitti V; Palluzzi F; Giacò L; Tamburrini G; Cecconi F; Nazio F; Sette C; Pagliarini V
    J Exp Clin Cancer Res; 2023 Aug; 42(1):214. PubMed ID: 37599362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation.
    Krajewska M; Dries R; Grassetti AV; Dust S; Gao Y; Huang H; Sharma B; Day DS; Kwiatkowski N; Pomaville M; Dodd O; Chipumuro E; Zhang T; Greenleaf AL; Yuan GC; Gray NS; Young RA; Geyer M; Gerber SA; George RE
    Nat Commun; 2019 Apr; 10(1):1757. PubMed ID: 30988284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression regulation by CDK12: a versatile kinase in cancer with functions beyond CTD phosphorylation.
    Choi SH; Kim S; Jones KA
    Exp Mol Med; 2020 May; 52(5):762-771. PubMed ID: 32451425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes.
    Chirackal Manavalan AP; Pilarova K; Kluge M; Bartholomeeusen K; Rajecky M; Oppelt J; Khirsariya P; Paruch K; Krejci L; Friedel CC; Blazek D
    EMBO Rep; 2019 Sep; 20(9):e47592. PubMed ID: 31347271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK12: an emerging therapeutic target for cancer.
    Lui GYL; Grandori C; Kemp CJ
    J Clin Pathol; 2018 Nov; 71(11):957-962. PubMed ID: 30104286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion.
    Tien JF; Mazloomian A; Cheng SG; Hughes CS; Chow CCT; Canapi LT; Oloumi A; Trigo-Gonzalez G; Bashashati A; Xu J; Chang VC; Shah SP; Aparicio S; Morin GB
    Nucleic Acids Res; 2017 Jun; 45(11):6698-6716. PubMed ID: 28334900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human cyclin-dependent kinase 12 (CDK12) and CDK13 complexes in C-terminal domain phosphorylation, gene transcription, and RNA processing.
    Liang K; Gao X; Gilmore JM; Florens L; Washburn MP; Smith E; Shilatifard A
    Mol Cell Biol; 2015 Mar; 35(6):928-38. PubMed ID: 25561469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK12 regulates DNA repair genes by suppressing intronic polyadenylation.
    Dubbury SJ; Boutz PL; Sharp PA
    Nature; 2018 Dec; 564(7734):141-145. PubMed ID: 30487607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma.
    Houles T; Boucher J; Lavoie G; MacLeod G; Lin S; Angers S; Roux PP
    Cell Death Discov; 2023 Dec; 9(1):459. PubMed ID: 38104154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK12 globally stimulates RNA polymerase II transcription elongation and carboxyl-terminal domain phosphorylation.
    Tellier M; Zaborowska J; Caizzi L; Mohammad E; Velychko T; Schwalb B; Ferrer-Vicens I; Blears D; Nojima T; Cramer P; Murphy S
    Nucleic Acids Res; 2020 Aug; 48(14):7712-7727. PubMed ID: 32805052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubule-specific cyclin-dependent kinase 12 knockdown potentiates kidney injury through transcriptional elongation defects.
    Zhang YL; Tang TT; Ni WJ; Li ZT; Jiang LY; Wang Y; Zhou X; Cao JY; Yin Q; Jiang W; Zhao YJ; Gan WH; Zhang AQ; Li ZL; Wen Y; Lv LL; Liu BC; Wang B
    Int J Biol Sci; 2024; 20(5):1669-1687. PubMed ID: 38481813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation.
    Chen HH; Wang YC; Fann MJ
    Mol Cell Biol; 2006 Apr; 26(7):2736-45. PubMed ID: 16537916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reversible inhibitor SR-4835 binds Cdk12/cyclin K in a noncanonical G-loop conformation.
    Schmitz M; Kaltheuner IH; Anand K; Düster R; Moecking J; Monastyrskyi A; Duckett DR; Roush WR; Geyer M
    J Biol Chem; 2024 Jan; 300(1):105501. PubMed ID: 38016516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription-associated cyclin-dependent kinase 12 (CDK12) as a potential target for cancer therapy.
    Wu W; Yu S; Yu X
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188842. PubMed ID: 36460141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles of CDK12 in tumorigenesis.
    Paculová H; Kohoutek J
    Cell Div; 2017; 12():7. PubMed ID: 29090014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors.
    Zhang T; Kwiatkowski N; Olson CM; Dixon-Clarke SE; Abraham BJ; Greifenberg AK; Ficarro SB; Elkins JM; Liang Y; Hannett NM; Manz T; Hao M; Bartkowiak B; Greenleaf AL; Marto JA; Geyer M; Bullock AN; Young RA; Gray NS
    Nat Chem Biol; 2016 Oct; 12(10):876-84. PubMed ID: 27571479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK13 cooperates with CDK12 to control global RNA polymerase II processivity.
    Fan Z; Devlin JR; Hogg SJ; Doyle MA; Harrison PF; Todorovski I; Cluse LA; Knight DA; Sandow JJ; Gregory G; Fox A; Beilharz TH; Kwiatkowski N; Scott NE; Vidakovic AT; Kelly GP; Svejstrup JQ; Geyer M; Gray NS; Vervoort SJ; Johnstone RW
    Sci Adv; 2020 May; 6(18):. PubMed ID: 32917631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th e role of CDK12 in tumor bio logy.
    Dzimková M; Procházková J; Klát J; Kohoutek J
    Klin Onkol; 2020; 33(4):260-267. PubMed ID: 32894954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of CDK12 as a Cancer Therapeutic Target and Related Inhibitors.
    Chen B; Liu J
    Curr Cancer Drug Targets; 2024 Jul; ():. PubMed ID: 38967076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.